January 2020 FDA Recall Drug by Ncs Healthcare Of Kentucky Inc
D-0850-2020 - Failed Impurities/Degradation Specification

This Class II drug recall was voluntarily initiated by Ncs Healthcare Of Kentucky Inc on January 28, 2020 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0850-2020

Reason for Recall
Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.
Initiated
01-28-2020
Reported
02-26-2020
Quantity
6929 blister cards

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
NCS Healthcare of Kentucky Inc
Nationwide in the USA.
Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39.

Batch or Lot Expiration Information

Lot# : 8170-9004, Exp 01/2020